[Do calcium antagonists inhibit the development of arteriosclerosis?].
Liszewska-Pfejfer
D
D
Kliniki Kardiologii Instytutu Chorób Wewnetrznych Akademii Medycznej, Warszawie.
Skarzyńska
M
M
D000818:Animals; D001158:Arteries / Q000378:metabolism*; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control*; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008055:Lipids / Q000037:antagonists & inhibitors; D008955:Models, Cardiovascular; D011817:Rabbits
D002121:Calcium Channel Blockers; D008055:Lipids; D002118:Calcium
Czy leki z grupy antagonistów wapnia hamuja rozwój miazdzycy?